Veracyte

$53.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-0.37%) Today

$0.00 (0.00%) As of 9:02 PM UTC after-hours

Why Robinhood?

You can buy or sell Veracyte and other stocks, options, and ETFs commission-free!

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA. The listed name for VCYT is Veracyte, Inc. Common Stock.

CEO

Bonnie H. Anderson

Employees

354

Headquarters

South San Francisco, California

Founded

2006

Market Cap

2.97B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

727.23K

High Today

$55.28

Low Today

$50.94

Open Price

$54.82

Volume

766.38K

52 Week High

$63.55

52 Week Low

$13.90

Collections

Analyst Ratings

71%

of 7 ratings

Buy

71%

Hold

14%

Sell

14%

VCYT Earnings

-$0.24

-$0.16

-$0.08

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 23, After Hours